TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs698761
log Bayes Factor = 0.0374399
Chromosome 2   position 44,547,574  (GRCh37) Explore rs698761 on Ensembl!
Variant rs698761 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T39.1 4-Aminophenol derivatives
0.191 0.809 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.188 0.812 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.176 0.824 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.173 0.827 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.171 0.829 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.165 0.835 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.164 0.836 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.158 0.842 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.156 0.844 0.000
T42.4 Benzodiazepines
0.155 0.845 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.151 0.849 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.149 0.851 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.148 0.852 0.000
T39.0 Salicylates
0.143 0.857 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.138 0.862 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.136 0.864 0.000
T43.2 Other and unspecified antidepressants
0.135 0.865 0.000
T39.4 Antirheumatics, not elsewhere classified
0.135 0.865 0.000
T39.2 Pyrazolone derivatives
0.135 0.865 0.000
T43.6 Psychostimulants with abuse potential
0.132 0.868 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.131 0.869 0.000
T42.1 Iminostilbenes
0.131 0.869 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.129 0.871 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.128 0.872 0.000
T36 Poisoning by systemic antibiotics
0.128 0.872 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.126 0.874 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.125 0.875 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.124 0.876 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.123 0.877 0.000
T42.2 Succinimides and oxazolidinediones
0.123 0.877 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.120 0.880 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.118 0.882 0.000
T43.9 Psychotropic drug, unspecified
0.117 0.883 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.117 0.883 0.000
T42.0 Hydantoin derivatives
0.115 0.885 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.113 0.886 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.112 0.888 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.112 0.888 0.000
T46.1 Calcium-channel blockers
0.105 0.895 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.105 0.895 0.000
T36.0 Penicillins
0.105 0.895 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.105 0.895 0.000
T40.4 Other synthetic narcotics
0.102 0.898 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.099 0.901 0.000
T46.7 Peripheral vasodilators
0.099 0.901 0.000
T47.2 Stimulant laxatives
0.098 0.901 0.000
T47.4 Other laxatives
0.098 0.902 0.000
T47.6 Antidiarrhoeal drugs
0.098 0.902 0.000
T40.2 Other opioids
0.098 0.902 0.000
T42.3 Barbiturates
0.097 0.903 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.097 0.903 0.000
T48.5 Anti-common-cold drugs
0.096 0.903 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.096 0.904 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.095 0.905 0.000
T38.9 Other and unspecified hormone antagonists
0.094 0.906 0.000
T38.7 Androgens and anabolic congeners
0.094 0.906 0.000
T38.4 Oral contraceptives
0.094 0.906 0.000
T38.2 Antithyroid drugs
0.094 0.906 0.000
T38.0 Glucocorticoids and synthetic analogues
0.094 0.906 0.000
T36.4 Tetracyclines
0.093 0.907 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.092 0.907 0.000
T48.4 Expectorants
0.092 0.907 0.000
T48.3 Antitussives
0.092 0.907 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.092 0.907 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.092 0.907 0.000
T48.0 Oxytocic drugs
0.092 0.907 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.092 0.908 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.092 0.908 0.000
T47.7 Emetics
0.092 0.908 0.000
T47.5 Digestants
0.092 0.908 0.000
T47.3 Saline and osmotic laxatives
0.092 0.908 0.000
T38.5 Other oestrogens and progestogens
0.092 0.908 0.000
T36.9 Systemic antibiotic, unspecified
0.092 0.908 0.000
T36.7 Antifungal antibiotics, systemically used
0.092 0.908 0.000
T36.6 Rifamycins
0.092 0.908 0.000
T36.5 Aminoglycosides
0.092 0.908 0.000
T36.2 Chloramphenicol group
0.092 0.908 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.092 0.908 0.000
T41.5 Therapeutic gases
0.091 0.909 0.000
T41.4 Anaesthetic, unspecified
0.091 0.909 0.000
T41.3 Local anaesthetics
0.091 0.909 0.000
T41.2 Other and unspecified general anaesthetics
0.091 0.909 0.000
T41.1 Intravenous anaesthetics
0.091 0.909 0.000
T41.0 Inhaled anaesthetics
0.091 0.909 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.090 0.910 0.000
T40.6 Other and unspecified narcotics
0.090 0.910 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.089 0.910 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.089 0.910 0.000
T40.8 Lysergide [LSD]
0.089 0.910 0.000
T40.7 Cannabis (derivatives)
0.089 0.910 0.000
T40.0 Opium
0.089 0.910 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.089 0.910 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.089 0.911 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.087 0.913 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.087 0.913 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.086 0.914 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.086 0.914 0.000
T37.5 Antiviral drugs
0.086 0.914 0.000
T37.4 Anthelminthics
0.086 0.914 0.000
T37.3 Other antiprotozoal drugs
0.086 0.914 0.000
T37.1 Antimycobacterial drugs
0.086 0.914 0.000
T37.0 Sulphonamides
0.086 0.914 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.086 0.914 0.000
T49.9 Topical agent, unspecified
0.085 0.915 0.000
T49.8 Other topical agents
0.085 0.915 0.000
T49.7 Dental drugs, topically applied
0.085 0.915 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.085 0.915 0.000
T49.5 Ophthalmological drugs and preparations
0.085 0.915 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.085 0.915 0.000
T49.3 Emollients, demulcents and protectants
0.085 0.915 0.000
T49.2 Local astringents and local detergents
0.085 0.915 0.000
T49.1 Antipruritics
0.085 0.915 0.000
T36.8 Other systemic antibiotics
0.084 0.915 0.000
T36.3 Macrolides
0.083 0.917 0.000
T40.1 Heroin
0.083 0.917 0.000
T40.3 Methadone
0.082 0.918 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.081 0.918 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.080 0.920 0.000
T47.0 Histamine H(2)-receptor antagonists
0.077 0.922 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.076 0.923 0.000
T38.1 Thyroid hormones and substitutes
0.076 0.924 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.075 0.925 0.000
T40.5 Cocaine
0.073 0.926 0.000
T50.1 Loop [high-ceiling] diuretics
0.072 0.927 0.000
T50.4 Drugs affecting uric acid metabolism
0.070 0.930 0.000
T50.7 Analeptics and opioid receptor antagonists
0.070 0.930 0.000
T50.5 Appetite depressants
0.070 0.930 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.070 0.930 0.000
T50.0 Mineralocorticoids and their antagonists
0.070 0.930 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.068 0.932 0.000
T45.2 Vitamins, not elsewhere classified
0.064 0.936 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.063 0.937 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.061 0.938 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.061 0.938 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.061 0.938 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.061 0.938 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.061 0.938 0.000
T44.0 Anticholinesterase agents
0.061 0.938 0.000
T45.4 Iron and its compounds
0.059 0.940 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.059 0.940 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.059 0.941 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.058 0.941 0.000
T45.8 Other primarily systemic and haematological agents
0.058 0.941 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.058 0.941 0.000
T45.6 Fibrinolysis-affecting drugs
0.058 0.941 0.000
T45.3 Enzymes, not elsewhere classified
0.058 0.941 0.000
T50.8 Diagnostic agents
0.058 0.941 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.057 0.943 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.053 0.947 0.000
T45.0 Antiallergic and antiemetic drugs
0.050 0.950 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.043 0.956 0.000
T45.5 Anticoagulants
0.040 0.960 0.000
N18.5 Chronic kidney disease, stage 5
0.000 0.962 0.038
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.968 0.032
E27.1 Primary adrenocortical insufficiency
0.000 0.969 0.031
E27 Other disorders of adrenal gland
0.000 0.970 0.030
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.027 0.973 0.001
E24 Cushing's syndrome
0.000 0.975 0.025
E20-E35 Disorders of other endocrine glands
0.000 0.975 0.025
E24.9 Cushing's syndrome, unspecified
0.000 0.977 0.023
E28 Ovarian dysfunction
0.000 0.977 0.023
E27.8 Other specified disorders of adrenal gland
0.000 0.977 0.023
N18.9 Chronic renal failure, unspecified
0.000 0.977 0.023
E28.3 Primary ovarian failure
0.000 0.978 0.022
E27.5 Adrenomedullary hyperfunction
0.000 0.978 0.022
E27.0 Other adrenocortical overactivity
0.000 0.978 0.022
N18 Chronic renal failure
0.000 0.978 0.022
E24.0 Pituitary-dependent Cushing's disease
0.000 0.979 0.021
E24.2 Drug-induced Cushing's syndrome
0.000 0.979 0.020
E34 Other endocrine disorders
0.000 0.980 0.020
E24.8 Other Cushing's syndrome
0.000 0.980 0.020
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.981 0.019
E25 Adrenogenital disorders
0.000 0.981 0.019
E29 Testicular dysfunction
0.000 0.982 0.018
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.982 0.018
E24.3 Ectopic ACTH syndrome
0.000 0.982 0.018
E24.1 Nelson's syndrome
0.000 0.982 0.018
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.982 0.018
E30 Disorders of puberty, not elsewhere classified
0.000 0.982 0.018
E31 Polyglandular dysfunction
0.000 0.982 0.018
E34.8 Other specified endocrine disorders
0.000 0.982 0.018
N18.0 End-stage renal disease
0.000 0.983 0.017
E32 Diseases of thymus
0.000 0.983 0.017
E28.9 Ovarian dysfunction, unspecified
0.000 0.983 0.017
E28.8 Other ovarian dysfunction
0.000 0.983 0.017
E28.1 Androgen excess
0.000 0.983 0.017
E28.0 Oestrogen excess
0.000 0.983 0.017
E20 Hypoparathyroidism
0.000 0.983 0.017
E28.2 Polycystic ovarian syndrome
0.000 0.983 0.017
E22 Hyperfunction of pituitary gland
0.000 0.983 0.017
E27.2 Addisonian crisis
0.000 0.984 0.015
N18.3 Chronic kidney disease, stage 3
0.000 0.985 0.015
N18.8 Other chronic renal failure
0.000 0.985 0.015
E27.9 Disorder of adrenal gland, unspecified
0.000 0.985 0.015
E26 Hyperaldosteronism
0.000 0.985 0.015
E29.9 Testicular dysfunction, unspecified
0.000 0.985 0.015
E34.3 Short stature, not elsewhere classified
0.000 0.985 0.015
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.985 0.015
E22.1 Hyperprolactinaemia
0.000 0.985 0.015
E34.5 Androgen resistance syndrome
0.000 0.985 0.014
E34.4 Constitutional tall stature
0.000 0.985 0.014
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.985 0.014
E34.1 Other hypersecretion of intestinal hormones
0.000 0.985 0.014
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.986 0.014
E23 Hypofunction and other disorders of pituitary gland
0.000 0.986 0.014
E25.9 Adrenogenital disorder, unspecified
0.000 0.986 0.014
E25.8 Other adrenogenital disorders
0.000 0.986 0.014
N18.1 Chronic kidney disease, stage 1
0.000 0.986 0.014
E29.8 Other testicular dysfunction
0.000 0.987 0.013
E29.0 Testicular hyperfunction
0.000 0.987 0.013
E34.9 Endocrine disorder, unspecified
0.000 0.987 0.013
E34.0 Carcinoid syndrome
0.000 0.987 0.013
E30.9 Disorder of puberty, unspecified
0.000 0.987 0.013
E30.8 Other disorders of puberty
0.000 0.987 0.013
E30.1 Precocious puberty
0.000 0.987 0.013
E30.0 Delayed puberty
0.000 0.987 0.013
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.987 0.013
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.987 0.013
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.987 0.013
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.987 0.013
E31.9 Polyglandular dysfunction, unspecified
0.000 0.987 0.013
E31.8 Other polyglandular dysfunction
0.000 0.987 0.013
E31.1 Polyglandular hyperfunction
0.000 0.987 0.013
E31.0 Autoimmune polyglandular failure
0.000 0.987 0.013
E32.9 Disease of thymus, unspecified
0.000 0.987 0.012
E32.1 Abscess of thymus
0.000 0.987 0.012
E32.0 Persistent hyperplasia of thymus
0.000 0.987 0.012
E20.8 Other hypoparathyroidism
0.000 0.988 0.012
E20.1 Pseudohypoparathyroidism
0.000 0.988 0.012
E20.0 Idiopathic hypoparathyroidism
0.000 0.988 0.012
E22.8 Other hyperfunction of pituitary gland
0.000 0.988 0.012
E22.0 Acromegaly and pituitary gigantism
0.000 0.988 0.012
E29.1 Testicular hypofunction
0.000 0.988 0.012
E32.8 Other diseases of thymus
0.000 0.988 0.011
E23.0 Hypopituitarism
0.000 0.989 0.011
E21.4 Other specified disorders of parathyroid gland
0.000 0.989 0.011
E26.8 Other hyperaldosteronism
0.000 0.989 0.011
E26.1 Secondary hyperaldosteronism
0.000 0.989 0.011
E20.9 Hypoparathyroidism, unspecified
0.000 0.989 0.011
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.989 0.011
E21.2 Other hyperparathyroidism
0.000 0.989 0.011
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.990 0.010
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.990 0.010
E23.1 Drug-induced hypopituitarism
0.000 0.990 0.010
E26.9 Hyperaldosteronism, unspecified
0.000 0.990 0.010
A63.0 Anogenital (venereal) warts
0.000 0.990 0.010
E23.2 Diabetes insipidus
0.000 0.991 0.009
E23.7 Disorder of pituitary gland, unspecified
0.000 0.991 0.009
N18.4 Chronic kidney disease, stage 4
0.000 0.991 0.009
E26.0 Primary hyperaldosteronism
0.000 0.991 0.009
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.009 0.991 0.000
Z94.0 Kidney transplant status
0.000 0.992 0.008
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.992 0.008
Z94.8 Other transplanted organ and tissue status
0.000 0.992 0.008
S02.10 Fracture of base of skull (closed)
0.008 0.992 0.000
Z57 Occupational exposure to risk-factors
0.007 0.993 0.000
Z57.2 Occupational exposure to dust
0.007 0.993 0.000
Z57.3 Occupational exposure to other air contaminants
0.007 0.993 0.000
Z94 Transplanted organ and tissue status
0.000 0.993 0.007
Z57.5 Occupational exposure to toxic agents in other industries
0.007 0.993 0.000
E23.6 Other disorders of pituitary gland
0.000 0.993 0.006
K11.5 Sialolithiasis
0.000 0.994 0.006
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances
0.006 0.994 0.000
Z63.7 Other stressful life events affecting family and household
0.006 0.994 0.000
Z56 Problems related to employment and unemployment
0.006 0.994 0.000
Z94.1 Heart transplant status
0.000 0.994 0.006
Z63 Other problems related to primary support group, including family circumstances
0.006 0.994 0.000
Z94.3 Heart and lungs transplant status
0.000 0.994 0.006
N20.0 Calculus of kidney
0.006 0.994 0.000
H04.2 Epiphora
0.000 0.994 0.006
Z57.9 Occupational exposure to unspecified risk-factor
0.005 0.994 0.000
Z57.7 Occupational exposure to vibration
0.005 0.994 0.000
Z57.6 Occupational exposure to extreme temperature
0.005 0.994 0.000
Z57.4 Occupational exposure to toxic agents in agriculture
0.005 0.994 0.000
Z57.1 Occupational exposure to radiation
0.005 0.994 0.000
Z57.0 Occupational exposure to noise
0.005 0.994 0.000
Z58 Problems related to physical environment
0.005 0.995 0.000
Z94.2 Lung transplant status
0.000 0.995 0.005
Z94.9 Transplanted organ and tissue status, unspecified
0.000 0.995 0.005
Z56.6 Other physical and mental strain related to work
0.005 0.995 0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified
0.000 0.995 0.005
Z56.3 Stressful work schedule
0.005 0.995 0.000
E21.0 Primary hyperparathyroidism
0.000 0.995 0.005
Z64 Problems related to certain psychosocial circumstances
0.005 0.995 0.000
Z56.7 Other and unspecified problems related to employment
0.005 0.995 0.000
Z56.0 Unemployment, unspecified
0.005 0.995 0.000
Z56.4 Discord with boss and workmates
0.005 0.995 0.000
Z94.5 Skin transplant status
0.000 0.995 0.005
Z94.6 Bone transplant status
0.000 0.995 0.005
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)
0.005 0.995 0.000
M62.5 Muscle wasting and atrophy, not elsewhere classified
0.005 0.995 0.000
Z29.2 Other prophylactic chemotherapy
0.005 0.995 0.000
Z65 Problems related to other psychosocial circumstances
0.005 0.995 0.000
N18.2 Chronic kidney disease, stage 2
0.001 0.995 0.004
H20.9 Iridocyclitis, unspecified
0.000 0.995 0.005
Z62 Other problems related to upbringing
0.005 0.995 0.000
Z55 Problems related to education and literacy
0.005 0.995 0.000
Z63.5 Disruption of family by separation and divorce
0.005 0.995 0.000
Z56.5 Uncongenial work
0.005 0.995 0.000
Z56.2 Threat of job loss
0.005 0.995 0.000
Z56.1 Change of job
0.005 0.995 0.000
Z58.5 Exposure to other pollution
0.005 0.995 0.000
K66.8 Other specified disorders of peritoneum
0.000 0.995 0.005
Z61 Problems related to negative life events in childhood
0.005 0.995 0.000
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)
0.005 0.995 0.000
Z63.9 Problem related to primary support group, unspecified
0.004 0.995 0.000
Z63.3 Absence of family member
0.004 0.995 0.000
Z63.2 Inadequate family support
0.004 0.995 0.000
Z63.1 Problems in relationship with parents and in-laws
0.004 0.995 0.000
Z63.4 Disappearance and death of family member
0.005 0.995 0.000
Z63.0 Problems in relationship with spouse or partner
0.005 0.995 0.000
Z63.6 Dependent relative needing care at home
0.004 0.995 0.000
Z64.0 Problems related to unwanted pregnancy
0.004 0.996 0.000
Z57.8 Occupational exposure to other risk-factors
0.004 0.996 0.000
C79 Secondary malignant neoplasm of other sites
0.004 0.996 0.000
Z58.7 Exposure to tobacco smoke
0.004 0.996 0.000
H26.4 After-cataract
0.000 0.996 0.004
H20.8 Other iridocyclitis
0.000 0.996 0.004
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.004 0.996 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.004 0.996 0.000
Z29.1 Prophylactic immunotherapy
0.004 0.996 0.000
Z58.9 Problem related to physical environment, unspecified
0.004 0.996 0.000
Z58.8 Other problems related to physical environment
0.004 0.996 0.000
Z58.6 Inadequate drinking-water supply
0.004 0.996 0.000
Z58.4 Exposure to radiation
0.004 0.996 0.000
Z58.3 Exposure to soil pollution
0.004 0.996 0.000
Z58.2 Exposure to water pollution
0.004 0.996 0.000
Z58.0 Exposure to noise
0.004 0.996 0.000
M62 Other disorders of muscle
0.004 0.996 0.000
M62.54 Muscle wasting and atrophy, not elsewhere classified (Hand)
0.004 0.996 0.000
C79.2 Secondary malignant neoplasm of skin
0.004 0.996 0.000
Z65.9 Problem related to unspecified psychosocial circumstances
0.004 0.996 0.000
A63.8 Other specified predominantly sexually transmitted diseases
0.000 0.996 0.004
Z64.4 Discord with counsellors
0.004 0.996 0.000
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful
0.004 0.996 0.000
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
0.004 0.996 0.000
Z64.1 Problems related to multiparity
0.004 0.996 0.000
Z65.3 Problems related to other legal circumstances
0.004 0.996 0.000
H20 Iridocyclitis
0.000 0.996 0.004
Z58.1 Exposure to air pollution
0.004 0.996 0.000
M62.58 Muscle wasting and atrophy, not elsewhere classified (Other)
0.004 0.996 0.000
Z29 Need for other prophylactic measures
0.004 0.996 0.000
Z59 Problems related to housing and economic circumstances
0.004 0.996 0.000
Z85.6 Personal history of leukaemia
0.000 0.996 0.004
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)
0.004 0.996 0.000
E21.3 Hyperparathyroidism, unspecified
0.000 0.996 0.004
M62.51 Muscle wasting and atrophy, not elsewhere classified (Shoulder region)
0.004 0.996 0.000
M62.57 Muscle wasting and atrophy, not elsewhere classified (Ankle and foot)
0.004 0.996 0.000
M62.53 Muscle wasting and atrophy, not elsewhere classified (Forearm)
0.004 0.996 0.000
M62.52 Muscle wasting and atrophy, not elsewhere classified (Upper arm)
0.004 0.996 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.004 0.996 0.000
Z65.5 Exposure to disaster, war and other hostilities
0.004 0.996 0.000
Z65.4 Victim of crime and terrorism
0.004 0.996 0.000
Z65.2 Problems related to release from prison
0.004 0.996 0.000
Z65.1 Imprisonment and other incarceration
0.004 0.996 0.000
Z65.0 Conviction in civil and criminal proceedings without imprisonment
0.004 0.996 0.000
C77.2 Intra-abdominal lymph nodes
0.000 0.996 0.004
M62.8 Other specified disorders of muscle
0.004 0.996 0.000
M62.6 Muscle strain
0.004 0.996 0.000
Z63.8 Other specified problems related to primary support group
0.004 0.996 0.000
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)
0.004 0.996 0.000
Z55.9 Problems relating to education and literacy, unspecified
0.004 0.996 0.000
Z55.8 Other problems relating to education and literacy
0.004 0.996 0.000
Z55.4 Educational maladjustment and discord with teachers and classmates
0.004 0.996 0.000
Z55.3 Underachievement in school
0.004 0.996 0.000
Z55.2 Failed examinations
0.004 0.996 0.000
Z55.1 Schooling unavailable and unattainable
0.004 0.996 0.000
Z55.0 Illiteracy and low-level literacy
0.004 0.996 0.000
Z62.9 Problem related to upbringing, unspecified
0.004 0.996 0.000
Z62.8 Other specified problems related to upbringing
0.004 0.996 0.000
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing
0.004 0.996 0.000
Z62.5 Other problems related to neglect in upbringing
0.004 0.996 0.000
Z62.4 Emotional neglect of child
0.004 0.996 0.000
Z62.3 Hostility towards and scapegoating of child
0.004 0.996 0.000
Z62.2 Institutional upbringing
0.004 0.996 0.000
Z62.1 Parental overprotection
0.004 0.996 0.000
Z62.0 Inadequate parental supervision and control
0.004 0.996 0.000
S42.20 Fracture of upper end of humerus (closed)
0.004 0.996 0.000
Z60 Problems related to social environment
0.004 0.996 0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group
0.004 0.996 0.000
K36 Other appendicitis
0.004 0.996 0.000
Z29.8 Other specified prophylactic measures
0.004 0.996 0.000
Z61.9 Negative life events in childhood, unspecified
0.003 0.996 0.000
Z61.7 Personal frightening experience in childhood
0.003 0.996 0.000
Z61.3 Events resulting in loss of self-esteem in childhood
0.003 0.996 0.000
Z61.2 Altered pattern of family relationships in childhood
0.003 0.996 0.000
Z61.1 Removal from home in childhood
0.003 0.996 0.000
Z61.0 Loss of love relationship in childhood
0.003 0.996 0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
0.004 0.996 0.000
M62.86 Other specified disorders of muscle (Lower leg)
0.004 0.996 0.000
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group
0.003 0.996 0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)
0.004 0.996 0.000
N17-N19 Renal failure
0.000 0.996 0.004
Z61.8 Other negative life events in childhood
0.003 0.996 0.000
R82.9 Other and unspecified abnormal finding in urine
0.000 0.996 0.004
Z61.6 Problems related to alleged physical abuse of child
0.003 0.996 0.000
M62.2 Ischaemic infarction of muscle
0.003 0.997 0.000
Z94.4 Liver transplant status
0.000 0.997 0.003
M62.65 Muscle strain (Pelvic region and thigh)
0.003 0.997 0.000
H20.0 Acute and subacute iridocyclitis
0.000 0.997 0.003
K38.8 Other specified diseases of appendix
0.003 0.997 0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.003 0.997 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.003 0.997 0.000
Z65.8 Other specified problems related to psychosocial circumstances
0.003 0.997 0.000
M62.1 Other rupture of muscle (nontraumatic)
0.003 0.997 0.000
Z60.8 Other problems related to social environment
0.003 0.997 0.000
M62.3 Immobility syndrome (paraplegic)
0.003 0.997 0.000
Z59.1 Inadequate housing
0.003 0.997 0.000
M62.66 Muscle strain (Lower leg)
0.003 0.997 0.000
Z99.2 Dependence on renal dialysis
0.000 0.997 0.003
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level
0.000 0.997 0.003
M62.0 Diastasis of muscle
0.003 0.997 0.000
N20 Calculus of kidney and ureter
0.003 0.997 0.000
H20.2 Lens-induced iridocyclitis
0.000 0.997 0.003
M62.4 Contracture of muscle
0.003 0.997 0.000
M62.84 Other specified disorders of muscle (Hand)
0.003 0.997 0.000
Z29.9 Prophylactic measure, unspecified
0.003 0.997 0.000
Z59.7 Insufficient social insurance and welfare support
0.003 0.997 0.000
Z59.6 Low income
0.003 0.997 0.000
Z59.5 Extreme poverty
0.003 0.997 0.000
Z59.3 Problems related to living in residential institution
0.003 0.997 0.000
Z59.4 Lack of adequate food
0.003 0.997 0.000
M62.83 Other specified disorders of muscle (Forearm)
0.003 0.997 0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified
0.003 0.997 0.000
M62.82 Other specified disorders of muscle (Upper arm)
0.003 0.997 0.000
S02.1 Fracture of base of skull
0.003 0.997 0.000
N20.1 Calculus of ureter
0.003 0.997 0.000
M62.80 Other specified disorders of muscle (Multiple sites)
0.003 0.997 0.000
Z59.2 Discord with neighbours, lodgers and landlord
0.003 0.997 0.000
M62.26 Ischaemic infarction of muscle (Lower leg)
0.003 0.997 0.000
M62.69 Muscle strain (Site unspecified)
0.003 0.997 0.000
M62.67 Muscle strain (Ankle and foot)
0.003 0.997 0.000
M62.64 Muscle strain (Hand)
0.003 0.997 0.000
M62.63 Muscle strain (Forearm)
0.003 0.997 0.000
M62.62 Muscle strain (Upper arm)
0.003 0.997 0.000
M62.61 Muscle strain (Shoulder region)
0.003 0.997 0.000
M62.60 Muscle strain (Multiple sites)
0.003 0.997 0.000
M62.81 Other specified disorders of muscle (Shoulder region)
0.003 0.997 0.000
Z60.9 Problem related to social environment, unspecified
0.003 0.997 0.000
M60.08 Infective myositis (Other)
0.003 0.997 0.000
Z94.7 Corneal transplant status
0.000 0.997 0.003
Z60.5 Target of perceived adverse discrimination and persecution
0.003 0.997 0.000
Z60.4 Social exclusion and rejection
0.003 0.997 0.000
Z60.3 Acculturation difficulty
0.003 0.997 0.000
Z60.1 Atypical parenting situation
0.003 0.997 0.000
Z60.0 Problems of adjustment to life-cycle transitions
0.003 0.997 0.000
E61.1 Iron deficiency
0.000 0.997 0.003
Y84.6 Urinary catheterisation
0.003 0.997 0.000
Z59.0 Homelessness
0.003 0.997 0.000
M62.88 Other specified disorders of muscle (Other)
0.003 0.997 0.000
M62.9 Disorder of muscle, unspecified
0.003 0.997 0.000
K38 Other diseases of appendix
0.003 0.997 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.003 0.997 0.000
M62.68 Muscle strain (Other)
0.003 0.997 0.000
M62.89 Other specified disorders of muscle (Site unspecified)
0.003 0.997 0.000
H20.1 Chronic iridocyclitis
0.000 0.997 0.003
M62.29 Ischaemic infarction of muscle (Site unspecified)
0.003 0.997 0.000
M62.28 Ischaemic infarction of muscle (Other)
0.003 0.997 0.000
M62.27 Ischaemic infarction of muscle (Ankle and foot)
0.003 0.997 0.000
M62.25 Ischaemic infarction of muscle (Pelvic region and thigh)
0.003 0.997 0.000
M62.24 Ischaemic infarction of muscle (Hand)
0.003 0.997 0.000
M62.23 Ischaemic infarction of muscle (Forearm)
0.003 0.997 0.000
M62.22 Ischaemic infarction of muscle (Upper arm)
0.003 0.997 0.000
M62.21 Ischaemic infarction of muscle (Shoulder region)
0.003 0.997 0.000
M62.20 Ischaemic infarction of muscle (Multiple sites)
0.003 0.997 0.000
M62.87 Other specified disorders of muscle (Ankle and foot)
0.003 0.997 0.000
M62.15 Other rupture of muscle (nontraumatic) (Pelvic region and thigh)
0.002 0.997 0.000
G30.9 Alzheimer's disease, unspecified
0.000 0.997 0.003
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.003 0.997 0.000
C79.6 Secondary malignant neoplasm of ovary
0.003 0.997 0.000
N20.9 Urinary calculus, unspecified
0.003 0.997 0.000
M62.19 Other rupture of muscle (nontraumatic) (Site unspecified)
0.002 0.997 0.000
M62.18 Other rupture of muscle (nontraumatic) (Other)
0.002 0.997 0.000
M62.17 Other rupture of muscle (nontraumatic) (Ankle and foot)
0.002 0.997 0.000
M62.16 Other rupture of muscle (nontraumatic) (Lower leg)
0.002 0.997 0.000
M62.14 Other rupture of muscle (nontraumatic) (Hand)
0.002 0.997 0.000
M62.13 Other rupture of muscle (nontraumatic) (Forearm)
0.002 0.997 0.000
M62.12 Other rupture of muscle (nontraumatic) (Upper arm)
0.002 0.997 0.000
M62.11 Other rupture of muscle (nontraumatic) (Shoulder region)
0.002 0.997 0.000
M62.10 Other rupture of muscle (nontraumatic) (Multiple sites)
0.002 0.997 0.000
M62.39 Immobility syndrome (paraplegic) (Site unspecified)
0.002 0.997 0.000
M62.38 Immobility syndrome (paraplegic) (Other)
0.002 0.997 0.000
M62.37 Immobility syndrome (paraplegic) (Ankle and foot)
0.002 0.997 0.000
M62.36 Immobility syndrome (paraplegic) (Lower leg)
0.002 0.997 0.000
M62.35 Immobility syndrome (paraplegic) (Pelvic region and thigh)
0.002 0.997 0.000
M62.34 Immobility syndrome (paraplegic) (Hand)
0.002 0.997 0.000
M62.33 Immobility syndrome (paraplegic) (Forearm)
0.002 0.997 0.000
M62.32 Immobility syndrome (paraplegic) (Upper arm)
0.002 0.997 0.000
M62.31 Immobility syndrome (paraplegic) (Shoulder region)
0.002 0.997 0.000
M62.30 Immobility syndrome (paraplegic) (Multiple sites)
0.002 0.997 0.000
D22.7 Melanocytic naevi of lower limb, including hip
0.000 0.997 0.003
N17 Acute renal failure
0.000 0.997 0.003
M62.09 Diastasis of muscle (Site unspecified)
0.002 0.997 0.000
M62.07 Diastasis of muscle (Ankle and foot)
0.002 0.997 0.000
M62.06 Diastasis of muscle (Lower leg)
0.002 0.997 0.000
M62.05 Diastasis of muscle (Pelvic region and thigh)
0.002 0.997 0.000
M62.04 Diastasis of muscle (Hand)
0.002 0.997 0.000
M62.03 Diastasis of muscle (Forearm)
0.002 0.997 0.000
M62.02 Diastasis of muscle (Upper arm)
0.002 0.997 0.000
M62.01 Diastasis of muscle (Shoulder region)
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.